Archive for the ‘Stem Cell Treatment’ Category

PRP & Stem Cell Treatment in Richmond VA – Dr. Bill Nordt …

Stem Cell Treatment | Posted by admin
Dec 03 2018

If youve been told that surgery was the only option to relieve your joint pain, you may considerStem Cell Therapy or Platelet Rich Plasma (PRP) Injection Therapyoffered by Dr. Nordt in Richmond, Virginia.

It is said that every pain has a story.Your situation and your pain are unique. Accordingly, you should expect treatment that is tailored specifically for you. Although Stem Cell and PRP Injection Therapy isnt for everyone, if youre suffering from acute or chronic pain in your knees, shoulders or hips, you may want to investigate these new fields of regenerative therapy.

These treatments use your bodys own repair mechanism and growth factors to promote healing.Stem cell therapy can be used to address various knee conditions.Many research laboratories are applying stem cell therapy to painful joint conditions.In theory, these cells can replicate, regenerate and restore healthy cellular tissue in areas of delayed or failed healing.

Stem Cell Therapy is a cutting-edge treatment that can be used to treat the pain and symptoms associated with a damaged joint. Pain from joint injury and deterioration is the result of multiple factors, including tissue damage, edema, and inflammation. Whenever possible, efforts to promote natural healing should be utilized. In those instances that ones own healing mechanism is inadequate, measures to jump-start the process may be indicated.

Stem cells are precursor cells and possess the capacity to transform into multiple tissue types. Stem cells are thought to have the potential to stimulate new growth and repair connective tissue. These cells enhance the bodys natural ability to heal itself, either through cell-to-cell mediation or genetic upregulation and matrix production.

Stem cells are either syringe- injected or surgically implanted into a joint to promote healing of the damaged ligaments, tendons and cartilage.

It should be noted that stem cells are still considered experimental in many orthopedic applications. Small or lesser degrees of tissue damage is more likely to benefit from any biological intervention. Stem cells may impart a mechanism to control inflammation, and in that event, can be helpful in any joint condition in which inflammation is a factor.

We are still in the process of understating just which conditions are most amenable to stem cell treatment. It is expected that over time, the indications and processes of stem cell injections will broaden.

Stem cells can be harvested from ones own bone marrow with a needle, known as a bone marrow aspiration or BMA. This can be performed under local or general anesthesia or with sedation. The bone marrow aspiration may be part of a larger surgery or a stand-alone procedure.

Stem cells can also be sourced from laboratories which are commercially prepared. Many commercial preparations are from the amniotic fluid of healthy newborns. They are delivered frozen and injected with a syringe.

Dr. Nordt is considered to be one of Richmonds leading providers of Stem Cell Therapy to be used in the treatment of degenerative various knee and shoulder disorders. To learn more about Stem Cell Therapy, contact Dr. Nordt s staff for more information.

Platelets are small discs that are derived from the fragmentation of precursor megakaryocytes. They play an important role in hemostasis and are a natural source of growth factors. Platelets are one of the key factors in forming blood clots and helping wounds heal.

Platelet Rich Plasma, or PRP, is blood plasma with concentrated amounts of platelets and other growth factors. The high levels of platelets found in PRP contain huge reservoirs of bioactive proteins, including growth factors and signaling proteins that are vital to initiate and accelerate tissue repair and regeneration.

To create Platelet Rich Plasma, a small amount of blood is taken from the patients arm. This blood is then placed in a centrifuge, where it is spun and the platelets are separated from the rest of the blood components. This takes less than 15 minutes and increases the concentration of platelets and growth factors up to 500%.

The specially prepared platelets are taken and reinjected into and around the point of injury. At this point in the process, the platelets release special growth factors that lead to tissue healing. By injecting injured areas with concentrated platelets, we can increase the growth factors up to five times which promotes temporary relief, is thought to promote overall healing, and stop any inflammation at the site of the injury.

PRP injection is a treatment option for various orthopedic injuries and conditions, which have traditionally required surgery or other extensive treatments. PRP injections are being utilized with increasing frequency and effectiveness in the field of orthopedic medicine.

Some common injuries that are treated with PRP injections include:

PRP injections are a fairly quick procedure that consists of drawing the blood to create Platelet Rich Plasma, preparing the PRP in the centrifuge, and then injecting the PRP into the affected area. The whole process is fairly quick and doesnt require anesthesia. This is a highly effective treatment that can be used to avoid intrusive joint surgery that would require a much longer period of rehabilitation.

Dr. Nordt is one or Richmonds leading providers of PRP Injection Therapy for the use of alleviating muscle and joint pain related to various orthopedic injuries and conditions. To learn more about PRP Injection Therapy, contact Dr. Nordts staff for more information.

See the rest here:
PRP & Stem Cell Treatment in Richmond VA - Dr. Bill Nordt ...

Stem Cell Therapy for Knees: Definitive Guide [with Patient …

Stem Cell Treatment | Posted by admin
Dec 03 2018

The stem cell procedure for the treatment of knee pain is minimally invasive, takes about 3 hours, and patients walk out of the office on their own following treatment. To start, stem cells are harvested from your abdominal or love handle fat using high tech, minimally-invasive liposuction equipment. Stem cells from your bone marrow are also utilized. The bone marrow concentrate is harvested using a specially designed, low-trauma needle which is placed into the posterior iliac crest under live x-ray guidance.

Mild IV sedation, in combination with local anesthetic, is used to provide patient comfort during the procedure. The harvested cells are then prepared for injection using an advanced separation and centrifugation process.

With the use of live x-ray guidance, the cells and growth factors are injected into the affected knee joint under sterile conditions. Dr. Brandts extensive experience with knee injections, along with the aid of the appropriate image guidance, ensures the cells are reaching their targeted area so you have the best chance for improvement.

To complement the high stem cell count achieved with the use of adipose derived stem cells, we often utilize PRP, A2M, and placental derived growth factors during our knee procedures and follow-up treatments.

Go here to see the original:
Stem Cell Therapy for Knees: Definitive Guide [with Patient ...

15 Stem Cell Therapy For Pain Questions, Answered

Stem Cell Treatment | Posted by admin
Nov 15 2018

Stem cell therapy is an exciting area of research that holds tremendous potential for helping chronic pain patients reduce their pain. Rapid advances in this field of medicine are buoying doctors and patients hopes that the exciting therapy could change lives. Advances are being made nearly every day, and as scientists further understand the nature of these cells, even more uses for them are becoming known. If youve ever wondered about how stem cell therapy for pain could help you, these 15 questions delve into how this therapy works and who it could be used for.

Science has a strong interest in stem cells because of their renewing properties and the ability of these cells to develop into any type of tissue in the body of the organism. Researchers believe that they have the potential for immeasurable clinical uses in health. Research is advancing many stem cell based therapies for people who suffer from diseases such as:

Mayo Clinic explains how this therapy works:

Stem cell therapy, also known as regenerative medicine, promotes the reparative response of diseased, dysfunctional or injured tissue using stem cells or their derivativesResearchers grow stem cells in a lab. These stem cells are manipulated to specialize into specific types of cells, such as heart muscle cells, blood cells or nerve cells. The specialized cells can then be implanted into a person.

Stem cell therapy is actually a type of treatment within the larger umbrella of regenerative medicine. Our longer post on regenerative medicine discusses the types of treatments available, including stem cell therapy and platelet-rich plasma injections.

Stem cells are essentially blank canvases that can transform into any type of cell in the human body. Specialized cells like bone cells, liver cells, and heart cells begin as stem cells. The process of the cells transforming from blank slates into specialized cells is called differentiation.

Stem cell therapy is the process of injecting these cells into damaged areas of the body, such as arthritic knees or shoulders. The stem cells then differentiate into damaged tissue, helping to regenerate the entire area.

There are two different types of natural stem cells and one that is genetically reprogrammed within the laboratory. Embryonic stem cells are the most immature and are found within the early stages of a growing embryo, usually after it has been left to develop five to six days. After the egg and sperm have united, the fertilized egg divides and creates stem cells that differentiate into the specialized cells the body requires to function. Many techniques using stem cells for pain therapies no longer rely on these types of stem cells.

The second type of stem cell, found naturally in organisms, is adult stem cells. These are present in developed tissue, such as muscle, skin, bone, brain, and blood. Also called tissue stem cells, they can self-renew and generate one specialized cell type. Under normal circumstances these tissue stem cells, or adult stem cells, will generate the type of cells that make up the organ in which they reside. These cells are used by the body to divide and repair injured areas or regenerate into specialized cells to replace the ones that are dead or damaged.

The third type of stem cells, which are genetically reprogrammed in the laboratory, are induced pluripotent stem cells. After years of stem cell research and development, it was discovered that artificially triggering certain genetic components would prompt different cells to become pluripotent stem cells, which were similar in nature to embryonic stem cells. This helps avoid ethical concerns associated with using human embryonic tissue for research and regenerative medicine.

The following video from an Arizona pain doctor goes into detail about how stem cell therapy for pain works.

There are twomajor types of stem cells: those harvested from adults and those harvested from embryonic tissues.

However, there are other ways to retrieve stem cells that reduce the use of embryonic stem cells, including:

As the Euro Stem Cell organization reports, some of these types of stem cells are more effective than others.

One source of stem cells is human embryos. These cells are called pluripotent stem cells, and theyre very useful to researchers because they can be multiplied indefinitely in the laboratory. Although these cells are often cultivated from embryos that are just a few days old, they can also be taken from fetal tissue thats older than eight weeks, according to the National Institutes of Health (NIH).

The majority of therapeutic stem cells come from adults. Even though embryos are the richest source of stem cells, humans of all ages have stem cells. Stem cells give adults the ability to replace damaged tissue, heal wounds, and grow hair.The patients own adult stem cells are extracted, purified, concentrated, and then injected into the damaged tissue. This process is usually non-surgical and the individual has very little recovery time. Most patients report only some soreness around the site of the injection. Sometimes there is also slight bruising. There have been no reports of serious side effects from treatments using stem cell therapy.

Newer research has given scientists the ability to reprogram specialized adult cells so they essentially return to their original stem cell state. These reprogrammed cells are known as induced pluripotent stem cells. Although this ability exists, scientists arent sure how or if these artificially created stem cells behave differently than other types.

Despite these unknowns, the reprogrammed stem cells are already being used in the development of medicines and helping scientists learn more about specific types of diseases, according to NIH.

Stem cells have many uses, and the full spectrum of their application isnt yet known. One way stem cells are helping researchers is by illuminating the inner workings of various diseases. Stem cells offer scientists the ability to model human disease progression in a laboratory setting.

This is exciting because many studies rely on animals with similar, but not exact, biology to humans. The more scientists can understand about human-specific disease progression, the greater insight they have regarding potential treatments.

For example, one of the earliest uses for stem cells were bone marrow transplants, used to help patients with leukemia or sickle cell anemia heal. This treatment has been used for more than 40 years. In addition, stem cell therapy may be used to treat:

The application of most interest to chronicpatients is likely the emerging field of regenerative medicine, which is the science of helping tissues regenerate. This field examines the potential of stem cells to repair damaged tissue and heal areas of the body bone and potentially organs, too affected by arthritis, diabetes, spinal cord injuries, nerve damage, Parkinsons disease, and more.

Exciting research has also uncovered the potential for stem cells to expand the number of lungs available for transplant. A portion of lungs available for transplant arent used because they become damaged. However, research from the American Physiological Society has found stem cells could help repair the organs and prepare them to save lives.

Other recent researchstories include:

For many of the studies underway, time is needed to fully examine the benefits and potential dangers of this treatment. Another obstacle is obtaining specific types of adult stem cells. Theyre difficult to grow in the laboratory, making it hard to produce the large numbers available for research.

Another potential issue with donor stem cells is the possibility of rejection. The immune system of the recipient could reject the cells, essentially making it difficult for the treatment to work as intended and causing ancillary problems.

Finally, since this is such a new treatment area, some government agencies are calling for more oversight of its use. Others are pushing back, claiming that stem cell therapy provides a new area of treatment for patients who have exhausted all other options.

That being said, even though there are complications and roadblocks to its use, the benefits of stem cell therapy could be huge. As the American Academy of Anti-Aging Medicine notes:

[A]n analysis of the potential benefits of stem cells based therapies indicates that 128 million people in the United States alone may benefit with the largest impact on patients with Cardiovascular disorders (5.5 million), autoimmune disorders (35 million) and diabetes (16 million US patients and more than 217 million worldwide).

Californias Stem Cell Agency gives a great overview of this process, noting:

In order to be approved by the FDA for use in human trials, stem cells must be grown in good manufacturing practice (GMP) conditions. Under GMP standards, a cell line has to be manufactured so that each group of cells is grown in an identical, repeatable, sterile environment. This ensures that each batch of cells has the same properties, and each person getting a stem cell therapy gets an equivalent treatment. Although the FDA hasnt yet issued guidelines for how pluripotent stem cells need to meet GMP standards, achieving this level of consistency could mean knowing the exact identity and quantity of every component involved in growing the cells.

Stem cell therapy is being studied for a number of chronic pain conditions, especiallypain in the:

Stem cell therapy for pain could help reduce the inflammation that results in chronic pain, or it could help to heal regenerative conditions that lead to pain, such as arthritis.

Using stem cell therapy for knee pain is one of the leading areas of research. Stem cell therapy for knees can be provided as stem cell injections or as blood platelet treatments from the body itself (another form of regenerative medicine).These two treatments may help relieve pain associated with:

The leading researchers on stem cell therapy for knee pain claim that it can help patients avoid surgery, with its associated costs and risks.

Since stem cell therapy promises to treat a number of conditions related to degenerative conditions, like arthritis and tendonitis, stem cell therapy may present a great treat option for hip pain related to these causes.

The National Multiple Sclerosis Society is leading the efforts in research, but currently reports the following:

At present, there are no approved stem cell therapies for MS. Larger, longer-term, controlled studies are needed to determine the safety and effectiveness of using stem cells to treat MS. When the results of these and subsequent clinical trials are available, it should be possible to determine what the optimal cells, delivery methods, safety and actual effectiveness of these current experimental therapies might be for different people with MS.

Potentially. One of our sister clinics, Arizona Pain, is participating in a study evaluating the potential of stem cells to reduce back pain related to degenerative disc disease. This progressive condition sometimes results from injury, but other times has no clear cause.

The study is exciting because it involves stem cells harvested from the bone marrow of healthy, young adults, and therefore itdoesnt come with the ethical concerns of embryonic stem cells. So far, the results have been very positive, and a significant number of people who received stem cells for their back pain have experienced reduced discomfort and improved quality of life.

This study is currently in Phase III, which is the phase immediately preceding potential FDA approval. This means it could soon be available to many more patients and potentially covered by insurance, although each insurance companys coverage policy varies.

Absolutely, and the research into this area is very promising. In fact, scientists have recently uncovered the specific type of stem cell most likely to reduce arthritis pain. Theyre special cells that are specifically able to rebuild tissue, bone, and cartilage, potentially offering much relief to osteoarthritis patients.

What other questions do you have regarding stem cell therapy for pain? If youre ready to learn more about using stem cell therapy to treatyour pain, click the button below to find a pain specialist in your area.

See original here:
15 Stem Cell Therapy For Pain Questions, Answered

Stem Cell Treatment Seen to Benefit Lupus Patients in …

Stem Cell Treatment | Posted by admin
Nov 15 2018

A single infusion ofmesenchymal stem cells (MSCs) those that make cells of the cartilage, bone, and fat decreased the number of auto-reactive immune cells in difficult-to-treat systemic lupus erythematosus (SLE) patients, a Phase 1 trial reports.

A Phase 2 study of this treatment is now opening in the U.S. and starting to recruiting eligible adults with lupus, ages 18 to 65.

Phase 1 findings were presented last month during the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) 2018 Annual Meetingin Chicago.The poster was tiled, Marked Immune Cell Subset Changes in Refractory Lupus Patients in a Phase I Trial of Allogenic Mesenchymal Stem Cells.

MSCs, a type of stem cell able to differentiate into bone, cartilage, connective tissue, muscle, and fat cells has shown promise as a potential therapy for lupus patients who fail to respond to conventional therapies.

The cells can be obtained from the umbilical cord, bone marrow, adipose tissue, muscle, and the lungs.

Researchers at the Medical University of South Carolina (MUSC)conducted a Phase 1 clinical trial to investigate the effects of umbilical cord-derived MSCs in six patients with hard-to treat, refractory SLE. Each patient received a single injection of one million cells per kg.

Researchers measured how the infusion affected the patients immune system, focusing on subsets of immune cells with key functions in lupus.

Among T-cells, researchers examined regulatory T-cells (Tregs) which dampen the activity of other immune cells and helper T-cells, important mediators of autoantibody production by B-cells in lupus patients.

Among B-cells, the researchers measured the levels of non-reactive B cells and abnormal memory B-cells, which arerelatively rare in healthy subjects but increased in SLE patients and associated with higher disease activity.

At 24 weeks post-treatment, the MSC infusion significantly reduced the amount ofabnormal memory B-cells and increased non-reactive B-cells compared to levels recorded at study start (baseline) infour of the six patients. In two patients, the therapy was also associated with an increase in Tregs, but that rise was modest compared to changes in B-cells.

In a previous study, the MUSC researchers identified two proteins, the glycoprotein-A repetitions predominant (GARP) and the transforming growth factor (TGF)-beta, as key regulators of B-cell activity.

GARP is a cell surface receptor for TGF-beta and the interaction between both proteins was shown to regulate the activity of B-cells and prevent autoimmunity.GARP is highly expressed on MSCs and the levels of GARP and TGF-beta were significantly increased in patients blood following the infusion of MSCs.

Overall, these results support the clinical benefits of MSCs in hard-to-treat lupus.

The researchers have since launched a double-blind and placebo-controlled Phase 2 trial (NCT02633163) to evaluate the efficacy and safety ofMSCs, given in combination with standard of care, in 81 adults with SLE.

The trial, currently recruiting, is taking place seven locations in six U.S. states, and enrollment information is available here.

Lupus patients will be randomized to one of two doses of MSCs a low dose of one million cells or a high dose of five million cells or to a placebo, each delivered a single time into the blood.

The trial aims to assess if patients treated with MSCs respond better than those given a placebo infusion plus standard of care.

Responders are defined as patients who experience a four-point or higher reduction inthe SystemicLupusErythematosusDisease Activity Index score (SLEDAI),and receiving corticosteroids at a dose of 10 mg a day or less.

Additional measures include frequency of disease flares, accumulation of new damage, and changes in health-related quality of life, fatigue, pain, and depression.

Read the original here:
Stem Cell Treatment Seen to Benefit Lupus Patients in ...

Stem cell therapies: FDA sets a new path – CNN

Stem Cell Treatment | Posted by admin
Nov 15 2018

Dr. Scott Gottlieb, the FDA commissioner, and Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, co-authored a new paper detailing the delicate balance between safety and innovation when it comes to the possibilities of using stem cells in medicine.

"However, despite the increasingly widespread use of stem cells in techniques being labeled as regenerative medicine, clinical benefit has not been clearly shown in most instances," Gottlieb and Marks wrote.

The FDA hopes to change that, while continuing efforts to regulate the industry.

"The FDA seems to be saying they want to find a sweet spot of stem cell oversight where they encourage innovation by good citizens and yet also carefully regulate this sphere as well as encouraging those interested in transplanting stem cells into patients to work with the FDA," he said.

Although Gottlieb and Marks didn't mention clinics in their paper, they noted that facilitating the availability of safe and effective therapies was part of the FDA's oversight of regenerative medicine products, including new stem cell therapies.

The FDA will provide tools to encourage individual or small groups of physicians to collaborate in support of the development of a stem cell or other regenerative medicine product, they wrote.

Gottlieb and Marks also said the FDA is encouraging investigators who are involved in such innovative product development to engage in dialogue with the agency early on in the research process.

"It feels like the FDA leadership is in essence telling them, 'Do the right thing, and we'll help you with a trial, even if you aren't a big university or company,' " Knoepfler said. "It's reassuring to see though that the FDA still emphasizes it is crucial to have data and follow the rules."

The ability to make such predictions could be a big step toward getting safe and effective FDA-approved treatments to patients in the future.

For many investigational stem cell-based products, it remains unclear whether the measurements currently used to characterize products will predict their clinical effectiveness, according to the FDA.

As of now, stem cell-based products submitted to the FDA in clinical trial proposals are characterized using a small number of cell surface markers and simple measures of cell product activity -- but is that enough to truly predict clinical outcomes?

"We can use some of this information to help generate standards in this field," he said. "There is a tremendous amount of interest now in developing standards that will facilitate the development of regenerative medicine and products."

All in all, "combined with the publication today of New England Journal of Medicine article, the FDA wants to assure that developers of regenerative medicine therapies understand the regulatory pathways that are available," the agency said in a written statement emailed to CNN by a FDA spokesperson.

"The FDA is committed to ensuring that patients have access to safe and effective regenerative medicine products as efficiently as possible. We are also committed to making sure we take action against products being unlawfully marketed that pose a potential significant risk to their safety," the statement said.

"The agency has adopted a risk-based and science-based approach that builds upon existing regulations to support innovative product development while clarifying the FDA's authorities and enforcement priorities. This risk-based approach allows product developers time to engage with the FDA, to determine if they need to submit a marketing authorization application and, if so, submit their application to the FDA for approval," the statement said.

More here:
Stem cell therapies: FDA sets a new path - CNN

#1 Guide To Stem Cell Therapy For Hair Loss In 2018

Stem Cell Treatment | Posted by admin
Nov 11 2018

Stem cell therapy may be the key to curing hair loss forever. But the technology is still in development.

In this article Ill look at how stem cell therapy works to restore lost hair. Ill help you decide if it could be a good option for you

And youll also find out how long you might have to wait before the treatment is available.

Advances in the understanding of stem cell biology may offer potential treatments for a variety of conditions, including hair loss, receding hairlines, and thinning hair.

While the research involving stem cells has been hampered by political influence in the past, there have been many recent advancements in the science of stem cell therapy and calls for further research.

Stem cell research holds promise for addressing a wide array of human malady, and some of the current research focuses on treating skin conditions and other causes of hair loss.

In basic terms, a stem cell is an undifferentiated cell that has the potential to develop into different types of cells within the body. According the the National Institutes of Health, stem cells also serve as a type of internal repair system for many tissues.

These cells have an almost limitless capacity to divide as long as the organism is alive, replenishing other cells indefinitely as cells grow through normal cycles of death and regeneration.

When a stem cell divides into two cells, each of these cells has the ability to remain a stem cell or become another type of more specialized cell such as epithelial or blood cells.

Currently, stem cells are divided into two sub-groups based on their origin, and are either embryonic or adult derived.

While the research being done on the potential for stem cell therapies to address spans a significant range, stem cell therapy does show promise for treating a variety of conditions including hair loss.

While the research being done on the potential for stem cell therapies to address spans a significant range, stem cell therapy does show promise for treating a variety of conditions including hair loss.

However, there remains a lack of detail knowledge and research related to the specific potential of stem cell biology and the development of stem cell therapies.

The Journals of Gerontology have published articles related on stem cell biology, and discussed the role of stem cells in the process of hair growth and how stem cell biology can be related to hair loss.

The authors acknowledge the role of stem cells in the maintenance and growth of bodily cells, including those related to hair growth.

One potential cause of hair loss and thinning hair may be related to a condition known as stem cell exhaustion, which can occur for many reasons including genetic diseases.

There is initial research in potential treatments for stem cell exhaustion, the prevention of which can help to stop related hair loss.

In a groundbreaking article published in Nature, the authors discuss the role of stem cells in hair growth and their research towards utilizing stem cell therapies to treat conditions of hair loss.

In order for hair growth to take place, the hair follicle requires epithelial stem cells for the propagation of growth.

Until recently, the process of developing stems cells that are differentiated into epithelial cells has not been possible.

One of the most promising treatments utilizing stem cell therapy comes from research out of China and Canada, where scientists have successfully been able to re-seed hairlines with epithelial stem cells.

Traditional treatments utilizing medication, or even hair follicle transplants, may work for a period of time but continued growth at the follicle has proven difficult to sustain.

These treatments are also unable to continuously regenerate new hair follicles once the treatment has ended.

The current studies on rodents provide some promise that some of the prior difficulties in using stem cells may have been solved through the use of a layer of dermal papilla cells that serve as a protective layer for the initial seeding process.

This coating has improved the therapeutic effect of the stem cell therapy, allowing the hair follicle to continue the normal process of morphogenesis and hair cycling.

Research from the University of Pennsylvania, funded by the US National Institutes of Health, has shown that converting stem cells that have not been differentiated into epithelial stem cells and injecting them into the skin of rodents will lead to the growth of human-like hair.

There remain some limitations to this treatment, including the fact that it has not yet been tested on human subject and that the growth that is seen does not include the sebaceous cells which are normally present in the growth of skin and epithelial cells.

The researchers also noted that some of the growth that took place were more representative of abnormal tumor-like lumps which would not be considered acceptable for treatment of hair loss or baldness in humans.

One study published in the US National Library of Medicine found that the number of hairs present in both males and females who received the treatment were significantly increased.

The same individual was treated on only half of their head, to provide a comparison, and it was found that the treatment side showed statistically significant improvements in the number of hairs.

The specific stem cells that were utilized are called adipose-derived stem cells.

While many of the potential treatments using stem cell therapy have only been tested on rodents, there remains promise in the continued and ongoing research that may address conditions of hair loss, receding hairlines, and thinning hair.

The most exciting aspect of stem cell therapies used to combat hair loss is that this type of treatment offers more long term solutions than hair transplants and has less potential for side effects than treatments involving medication or supplements.

Due to the relatively recent development of stem cell therapies, there remain a significant amount of unknowns about the potential treatments as well as the potential side effects.

The intention of stem cell therapies for treating hair loss is to encourage the growth and generation of epithelial cells, which are necessary for hair growth. However, one of the potential side effects according to a leader in stem cell research is that stem cell treatments can lead to the growth of benign tumors.

The goal is to induce cellular generation, but it can be difficult to ensure the generation of cells is isolated to the growth of hair. Another side effect that has been identified among researchers is that individuals undergoing a form of stem cell therapy commonly have aa weakened immune system

While scientists and researchers have known about the potential of stem cells for decades, the use of stem cell therapies has been somewhat controversial due to where stem cells can be obtained from.

According to the US Department of Health & Human Services, scientists have been utilizing two types of stem cells for research.

The two types of stem cells are embryonic stem cells or somatic/adult stem cells. The cultivation of human embryonic stem cells became controversial due to the nature of their propagation, and the types of research allowed became subject to significant limitations.

Recent advancements in stem cell research have allowed scientists to use the less controversial somatic/adult stem cells in areas of research and potential therapeutic options.

These advancements have made stem cell therapy significantly less controversial and opened up significant possibilities for the future of stem cell research and stem cell therapy.

There is still a significant amount of research to be done on the potential of stem cell therapy, however there are treatments available utilizing stem cells.

Unlike transplants of the past, hair stem cell transplantation utilizes an individuals own naturally developed hair follicles and adult derived stem cells to promote growth in an area where the hair has thinned or receded.

The area from which the follicles are harvested are not damaged and new hair growth will continue, and the area to which the follicles and adult derived stem cells are implanted will begin full hair growth in a matter of weeks.

This process is virtually painless, has limited potential for side effects, and does is not controversial due to the fact that the adult derived stem cells are obtained from the individual themselves.

There are currently limited options for stem cell therapies to address issues of hair loss, thinning hair, and receding hairlines. However, much of the current research being done shows significant promise for the further development of stem cell therapies that will be able to better address such issues.

One of the most intriguing aspects of the use of stem cell therapies for issues of hair loss is that these types of treatments may be able to address many of the underlying conditions that cause hair loss.

The future of stem cell therapies to treat baldness that occurs for a variety of underlying reasons is quite bright, and while the current treatments are in their infancy the potential held in stem cell research is quite promising.

See the article here:
#1 Guide To Stem Cell Therapy For Hair Loss In 2018

Stem Cell Therapy for Anti-Aging and Sexual Performance …

Stem Cell Treatment | Posted by admin
Nov 11 2018

Stem Cell Therapy has been around for quite some time, but due to high cost it was primarily used for recovery in athletes and the financial elite. However, with the progression of science and knowledge, stem cell therapy has become much more widely used and financially attainable.

Tampa Rejuvenation is the first in Tampa Bay to utilize the benefits of stem cell therapy for the purpose of anti-aging and sexual performance. We realize as our patients age, their bodies no longer have the regenerative properties to attain the desired results from using their growth factors alone as with our PRP, or Plasma Rich Platelet, therapy. Although many patients will still yield improvement with the PRP alone, the magnitude of cytokines and growth factors in your blood as you age will deplete with age. By implementing stem cell therapy, the number of growth factors are exponential allowing our bodies to regenerate on a magnitude that is otherwise unattainable with some results lasting for 3-5 years.

Stem Cell Therapy can be used to restore vitality to the skin, encourage the growth of hair, and even restore sexual performance and pleasure.

Originally posted here:
Stem Cell Therapy for Anti-Aging and Sexual Performance ...

Is Stem Cell Therapy Covered by Medicare?

Stem Cell Treatment | Posted by admin
Nov 11 2018

Stem cell therapy has been a hot topic in the press lately. With more and more medical providers offering stem cell treatments, patients around the country have been wondering, Is Stem Cell Therapy covered by Medicare.

Stem Cell research has shown that its an effective treatment for chronic joint pain and arthritis sufferers and more recent studies are starting to show the benefit for treatment of neurological disorders as well. (M.S., Parkinsons, and Stroke)

So the team at Stem Cell: The Magazine, have put together some information to answer this question of insurance coverage for potential medical enrollees seeking stem cell and regenerative treatments.

So what is the answer to Does Medicare cover Stem Cell therapy?

From the research that we have pulled up regarding Medicare Insurance Coverage for stem cell therapy; medicare does cover stem cell treatments, but not for some of the chronic degenerative conditions that regenerative treatments (stem cell therapy) can help them with.

INDICATIONS FOR COVERAGE

Section 2.a Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) eligible for coverage in the following: a) The treatment of leukemia b) The treatment of severe combined immunodeficiency disease (SCID) and for the treatment of Wiskott-Aldrich syndrome. OR c) The treatment of Myelodysplastic Syndromes (MDS) pursuant to Coverage with Evidence Development (CED) in the context of a Medicare-approved, prospective clinical study. 3. Autologous Stem Cell Transplantation(AuSCT) is eligible for coverage in the following: a) Acute leukemia in remission who have a high probability of relapse and who have no human leucocyte antigens (HLA)-matched; OR b) Resistant non-Hodgkins lymphomas or those presenting with poor prognostic features following an initial response; OR c) Recurrent or refractory neuroblastoma; OR d) Advanced Hodgkins disease who have failed conventional therapy and have no HLA-matched donor.

You can see that outside of the listed conditions above, Medicare does not cover stem cell therapy for treatments joint conditions or neurological conditions that patients are more commonly seeking treatment for.

The orthopedic application of stem-cell therapy is not addressed within the stem cell transplantation NCD. (NCD = National Care Determinations)

What this means for any patient that is looking to receive regenerative and stem cell treatments for orthopedic conditions such as:

M

M

Medicare will not cover treatment for these conditions. In fact, most major medical carriers will not provide coverage for these treatments either.

Many chronic joint pain sufferers wonder why Medicare and most major carriers dont provide coverage for these treatments if they are so effective, but there is a simple answer for why this is.

Medicare and most major health insurance are for emergency conditions. Regenerative medicine is still considered an elective treatment, close to wellness care. Insurance carriers are not in the business of providing wellness for coverage for their participants.

Our hope at Stem Cell: The Magazine is that as more and more patients continue to seek out treatment of their orthopedic and neurological conditions using stem cell and regenerative treatments, that Mediare and major health insurances will accept stem cell as the first treatment for these chronic conditions.

Is Stem Cell Therapy Covered by Medicare? was last modified: October 3rd, 2018 by Stem Cell The Magazine

Read the rest here:
Is Stem Cell Therapy Covered by Medicare?

NSI Stem Cell | Peripheral Neuropathy Stem Cell Therapy

Stem Cell Treatment | Posted by admin
Nov 11 2018

Therapy for Neuropathy

Neuropathysufferers now have a new, minimally invasive therapy option. Stem cell therapy is an alternative, revolutionary approach to relieving your neuropathy pain and symptoms. A stem cells primary function is to repair and regenerate damaged tissue. When applied, they seek out any tissue in the body that is damaged and repair it, leading to improved function.

For many people, especially those who have diabetes, peripheral neuropathy most often occurs in the feet. The discomfort is most commonly described as a sharpness, shooting, or burning. Some describe it as a feeling as if they were getting electric shocks.

No matter how the pain or tingling is described, the core reason for it is nerve damage. Stem cell-based therapy for peripheral neuropathy works to repair damaged nerves and rebuild new nerve connections.

This new therapy for neuropathy does more than just heal nerve damage. It also addresses glial cells and cytokine inflammation, which has a significant role in both the development of and the progression of neuropathy.

Neuropathic pain, including that produced by idiopathic peripheral neuropathy, doesnt always respond well to pain medication or other pharmaceutical drugs. Even when it does, there are often unwelcome side effects that accompany the response, such as weight gain, drowsiness, dry mouth, or negative mood changes.

The National Stem Cell Institutes proprietary stem cell therapy for neuropathy uses mesenchymal stem cells (MSCs) derived from the patients adipose tissue or bone marrow, so you dont have to worry that your our new therapy for neuropathy is adding to the risks and side effects of any medication.These are not embryonic stem cells or cells from fetuses. These regenerative cells come straight from your own body just a few hours before they are injected back into your body and put to work to heal disease or dysfunction. The safety of stem cell therapy procedures has been well established in countless studies and research.

After stem cell therapy for neuropathy, patients experience relief from Neuropathy Pain.* Scar tissues begin to heal and reverse to healthy tissue while inflammation and pain are relieved. This relief allows patients to increase their daily activities and movement, getting them back to a healthier, happier life.

NSIs proprietary stem cell therapy for neuropathy requires no overnight stays in a hospital. Its done on an outpatient basis with little to minimal downtime post-procedure. Most people return to their usual, everyday activities the very same day.

Youve probably seen quite a bit in the news about the dangers of pain medications such as opioids. Some researchers are studying alternatives to such risky medications and, for many patients, stem cell therapy for neuropathy may be an excellent choice.

Neuropathic pain frequently doesnt respond well to morphine or other opioid-based medication. But even if you arent taking such potent drugs for your neuropathic symptoms, your body can still build up a tolerance for whatever you do take. This can result in the need for higher and higher doses.

In many cases, the higher a patients dose of pain medication, the greater the side effects. Depending on the drug, these can include

Our new therapy for neuropathy, however, is a safe, drug-free alternative to medications. There is no risk of addiction or dependency because stem cells are not manufactured pharmaceuticals. They are a natural part of your body and are, in fact, the basis of all healing within the body.

Continue reading here:
NSI Stem Cell | Peripheral Neuropathy Stem Cell Therapy

Stem Cell Therapy – Top Rated Local Stem Cell Treatment …

Stem Cell Treatment | Posted by admin
Nov 11 2018

What are stem cells?

Stem cells are the basic building blocks of human tissue and have the ability to repair, rebuild, and rejuvenate tissues in the body. When a disease or injury strikes, stem cells respond to specific signals and set about to facilitate the healing process by stimulating your own body to repair itself.

Stem cells that come from perinatal tissue(healthy post-natal C-sections) have distinct functional properties including immunomodulation and anti-inflammation which support the repair and regeneration of damaged tissue associated with disease and injury.

There are four known types of stem cells which include:

We provide allogeneic regenerative cytokines and mesenchymal stem cells from health post-natal C-sections.

We tap into our bodys stem cell reserve daily to repair and replace damaged or diseased tissue. When the bodys reserve is limited and as it becomes depleted, the regenerative power of our body decreases and we succumb to disease and injury.

Three sources of stem cells from a patients body are used clinically which include adipose tissue (fat), bone marrow and umbilical cord matrix(Whartons Jelly).

We provide stem cell therapy for a wide variety of musculoskeletal conditions for which traditional treatment offers less than optimal options. Some conditions include Osteoarthritis, Bursitis, Plantar Fasciitis and Degenerative Disc Disease

Since each condition and patient are unique, there is no guarantee of what results will be achieved or how quickly they may be observed. According to patient feedback, many patients report results in one to three months, however, it may take as long as six to nine months. Individuals interested in stem cell therapy are urged to consult with their physician before choosing investigational allogeneic umbilical cord derived regenerative medicine allografts as a treatment option.

In order to determine if you are a good candidate for a regenerative medicine treatment, you will need to complete a medical history form which will be provided by our patient advocate team. Once you complete and submit your medical history form, our medical team will review your records and determine if you are a qualified candidate for a regenerative medicine therapy.

The side effects of intra-articular injection of a regenerative medicine allograft are minimal and may include but are not limited to: infection, minor bleeding at the treatment sites and localized pain. However, these side effects typically last no longer than 24 hours.

We provide regenerative medicine allografts from healthy post-natal C-section births that provide regenerative factors and mesenchymal stem cells. Embryonic stem cells are typically associated with ethical concerns. We do not offer embryonic stem cells.

Our regenerative medicine allografts are regulated as human cell and tissue transplants, similar to skin and bone. As structural human cell and tissue products regulated under FDA CFR 1271 Part 361, our allografts do not require FDA approval, rather we are strictly regulated to prevent the spread of communicable diseases and to maintain the structural integrity of the allografts as theyre harvested from umbilical cords and transferred for musculoskeletal cushioning, protection and supplementation. These regenerative allografts are FDA regulated rather than FDA approved. The FDA is a regulatory oversight body and doesnt exercise legal authority. If an FDA regulated tissue transplant or therapy is noted as non-compliant and not corrected according to FDA guidelines, the FDA may refer a significant public health risk to the Department of Justice or a state attorney general.

Stem cell treatment is not covered by health insurance at this time.

Although stem cells are found throughout our bodies, mesenchymal stem cells can only be harvested for native (non-cultured) use from adipose, bone marrow and umbilical cord matrix. The term amniotic stem cells is an oxymoron in that amniotic fluid and matrix products dont contain stem cells. They do however contain unique cytokines and other growth factors.

Follow this link:
Stem Cell Therapy - Top Rated Local Stem Cell Treatment ...